Clinical Perspectives on HER2-Targeted Antibody-Drug Conjugates: Treatment-Related Adverse Events

Do you know how to safely manage treatment-related adverse events (TRAEs) associated with human epidermal growth factor receptor 2 (HER2)-targeted antibody-drug conjugates (ADCs)? Credit available for this activity expires: 6/14/2023 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/975383?src=mkm_podcast_addon_975383